Drug profile · INN
tolazoline hydrochloride
PRISCOLINE
tolazoline hydrochloride (PRISCOLINE) is a adrenergic receptor alpha antagonist. Route of administration: injection. Current US regulatory status: approved.
Drug details — tolazoline hydrochloride
- US status
- approved
- Class
- —
- Route
- INJECTION
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
tolazoline hydrochloride (PRISCOLINE) is a adrenergic receptor alpha antagonist. Route of administration: injection. Current US regulatory status: approved.
Key facts
Mechanism of action
Adrenergic receptor alpha antagonist
Primary target: Adrenergic receptor alpha
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is tolazoline hydrochloride?
tolazoline hydrochloride (PRISCOLINE) is a adrenergic receptor alpha antagonist. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for tolazoline hydrochloride?
PRISCOLINE is a marketed brand name for tolazoline hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of tolazoline hydrochloride?
tolazoline hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.